Loading... Please wait... Loading... Please wait...
ESTIMATED
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $2.39 | $2.39 | $2.39 |
| Q2 2024 | 0 | $2.01 | $2.01 | $2.01 |
| Q3 2024 | 0 | $2.30 | $2.30 | $2.30 |
Genetic Technologies Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 3.96 M for the quarter and had revenue of 8.69 M for the year. Genetic Technologies Limited has generated $0 earnings per share over the last year ($-0.12 diluted earnings per share) and currently has a price-to-earnings ratio of -12.6. Genetic Technologies Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 28th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 12/29/2023 | Q2 2024 | -$0.06 | $3.92 M | $3.96 M | 09/29/2023 | Q1 2024 | -$0.03 | $2.44 M | 08/30/2023 | Q4 2023 | -$0.07 | $4.53 M | 03/30/2023 | Q3 2023 | -$0.03 | $2.69 M | 12/30/2022 | Q2 2023 | -$0.06 | $4.15 M | 09/29/2022 | Q1 2023 | -$0.03 | $2.49 M | 08/30/2022 | Q4 2022 | -$0.04 | $4.74 M | 03/30/2022 | Q3 2022 | -$0.02 | $2.88 M | 02/24/2022 | Q2 2022 | -$0.04 | $2.05 M | 09/29/2021 | Q1 2022 | -$0.02 | $1.73 M | 08/31/2021 | Q4 2021 | -$0.04 | $104,118 | 03/30/2021 | Q3 2021 | -$0.02 | $659,149 | 12/30/2020 | Q2 2021 | -$0.04 | $16,436 | 09/18/2020 | Q1 2021 | -$0.02 | $8,218 | 10/22/2020 | Q4 2020 | -$0.07 | $9,278 | 03/30/2020 | Q3 2020 | -$0.04 | $4,639 | 02/27/2020 | Q2 2020 | -$0.08 | $586 | 09/29/2019 | Q1 2020 | -$0.04 | $293 | 10/03/2019 | Q4 2019 | -$0.11 | $7,042 | 03/30/2019 | Q3 2019 | -$0.06 | $3,521 |
|---|
A. Genetic Technologies Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 28th, 2024 based off last year's report dates.
A. The conference call for Genetic Technologies Limited's latest earnings report can be listened to online.
A. The conference call transcript for Genetic Technologies Limited's latest earnings report can be read online.
A. Genetic Technologies Limited (NASDAQ:GENE) has a recorded annual revenue of $8.69 M.
A. Genetic Technologies Limited (NASDAQ:GENE) has a recorded net income of $8.69 M. Genetic Technologies Limited has generated $-0.12 earnings per share over the last four quarters.
A. Genetic Technologies Limited (NASDAQ:GENE) has a price-to-earnings ratio of -12.6 and price/earnings-to-growth ratio is -0.3.
